Stealth BioTherapeutics Corp MITO
Set alert
0.32 +0.32 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 23.54M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -6.40
- Beta
- 1.46
- Short ratio
- 1.77
- Inst. own
- 7.86%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 17, 2022
- 50-d avg
- 0.315554
- 200-d avg
- 0.368184
- 1y target
- 1.77
Valuation
P/E -0.7×
FY 2016 5y median -1.4× FY 2021
P/S 0.0×
FY 2016 5y median 0.0× FY 2021
P/B -0.8×
FY 2016 5y median -0.6× FY 2021
P/FCF -0.9×
FY 2016 5y median -2.1× FY 2021
EV/EBITDA -0.1×
FY 2016 5y median -1.0× FY 2021
EV/Sales 0.0×
FY 2016 5y median 0.0× FY 2021
FCF Yield -117.1%
FY 2016 5y median -47.1% FY 2021
Profitability
Gross Margin 0.0%
FY 2016 5y median 0.0% FY 2021
Operating Margin 0.0%
FY 2016 5y median 0.0% FY 2021
Net Margin 0.0%
FY 2016 5y median 0.0% FY 2021
ROE 118.7%
FY 2016 5y median 28.5% FY 2021
ROIC -130.2%
FY 2016 5y median -130.2% FY 2021
ROA -107.1%
FY 2016 5y median -160.3% FY 2021
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2021
Operating Income -5.4%
FY 2016 FY 2021
EPS (diluted) 6.5%
FY 2016 FY 2021
Free Cash Flow 15.9%
FY 2016 FY 2021
Financial Health
Current Ratio 4.6×
FY 2016 5y median 1.5× FY 2021
Quick Ratio 4.6×
FY 2016 5y median 1.5× FY 2021
Debt / Equity -0.3×
FY 2016 5y median -0.3× FY 2021
Net Debt / EBITDA 0.7×
FY 2016 5y median 0.4× FY 2021
Interest Coverage -41.3×
FY 2016 5y median -24.3× FY 2021
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2021
Annual · latest fiscal year ends 2021-12-31